WO2001032856A2 - Seed-preferred promoter from barley - Google Patents

Seed-preferred promoter from barley Download PDF

Info

Publication number
WO2001032856A2
WO2001032856A2 PCT/US2000/030537 US0030537W WO0132856A2 WO 2001032856 A2 WO2001032856 A2 WO 2001032856A2 US 0030537 W US0030537 W US 0030537W WO 0132856 A2 WO0132856 A2 WO 0132856A2
Authority
WO
WIPO (PCT)
Prior art keywords
plant
promoter
seed
nucleotide sequence
sequence
Prior art date
Application number
PCT/US2000/030537
Other languages
English (en)
French (fr)
Other versions
WO2001032856A3 (en
Inventor
Shuping Jiao
Jeffrey E. Habben
Xiaomu Niu
Odd-Arne Olsen
Original Assignee
Pioneer Hi-Bred International, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pioneer Hi-Bred International, Inc. filed Critical Pioneer Hi-Bred International, Inc.
Priority to HU0203063A priority Critical patent/HUP0203063A3/hu
Priority to EP00976984A priority patent/EP1226261A2/en
Priority to MXPA02004307A priority patent/MXPA02004307A/es
Priority to CA002389759A priority patent/CA2389759A1/en
Priority to AU14684/01A priority patent/AU1468401A/en
Publication of WO2001032856A2 publication Critical patent/WO2001032856A2/en
Publication of WO2001032856A3 publication Critical patent/WO2001032856A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823—Reproductive tissue-specific promoters
    • C12N15/8234—Seed-specific, e.g. embryo, endosperm
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Definitions

  • the present invention relates to the field of plant molecular biology, more particularly to regulation of gene expression in plants.
  • heterologous DNA sequences in a plant host is dependent upon the presence of an operably-linked promoter that is functional within the plant host. Choice of the promoter sequence will determine when and where within the plant the heterologous DNA sequence is expressed. Where continuous expression is desired throughout the cells of a plant, constitutive promoters are utilized. In contrast, where gene expression in response to a stimulus is desired, inducible promoters are the regulatory element of choice. Where expression in specific tissues or organs is desired, tissue-preferred promoters are used. That is, these promoters can drive expression in specific tissues or organs.
  • Additional regulatory sequences upstream and/or downstream from the core promoter sequence can be included in expression cassettes of transformation vectors to bring about varying levels of expression of heterologous nucleotide sequences in a transgenic plant. See, for example, U.S. Patent No. 5,850,018.
  • Regulatory sequences may also be useful in controlling temporal and/or spatial expression of endogenous DNA.
  • specialized tissues are involved in fertilization and seed development. Identification of promoters which are active in these seed tissues is of interest. In grain crops of agronomic importance, seed formation is the ultimate goal of plant development. Seeds are harvested for use in food, feed, and industrial products. The quantities and proportions of protein, oil, and starch components in those seeds determine their utility and value.
  • the timing of seed development is critical. Environmental conditions at any point prior to fertilization through seed maturation may affect the quality and quantity of seed produced. In particular, the first 10 to 12 days after pollination (the lag phase) are critical in maize seed development. Several developmental events during the lag phase are important determinants of the fate of subsequent seed growth and development. (Cheikh, N. et al., Plant Physiology 106:45-51 (1994)) Therefore, a means to influence plant development, particularly in response to stress during this phase of growth, is of interest. Identification of a promoter sequence active in tissues of developing seeds exposed to abiotic stresses would be useful. Specialized plant tissues are central to seed development.
  • a short-distance transport mechanism operates to move the assimilates from the vascular tissues to the endosperm and embryo.
  • photosynthate enters the seed via the pedicel; in wheat and barley, via the nucellar projection and the aleurone layer. It is possible that this short-distance assimilate pathway between the phloem and the endosperm can operate to regulate the rate of sucrose transport into the grain.
  • a promoter active in gene expression within these specialized tissues such as the nucellar projection or pedicel, may have significant effects on grain development.
  • sucrose is unloaded passively from the phloem into the apoplast of the pedicel parenchyma and inverted to hexose sugars by a cell-wall-bound acid invertase.
  • the hydrolysis of sucrose in the apoplast maintains a favorable gradient for continued unloading from the phloem and provides hexoses that are taken up by the basal endosperm cells. It has been shown that maize seeds induced to abort, in vitro, have only low levels of invertase activity in the pedicel. (Hanft, J.M. et al. (1986) Plant Physiol.
  • the maize Glb1 gene encodes globulin-1 , a major embryo storage protein.
  • Glb1 is expressed in the developing maize seed during embryo development.
  • the promoter region of Glb1 has been identified, cloned, and introduced into tobacco plants by Agrobacter/i/m-mediated transformation. (Liu, S., et al. (1996) Plant Cell Reports 16:158-162)
  • the transformed plants demonstrate that the Glb1 promoter has desirable temporal and tissue specificity.
  • the Glb1 promoter is positively regulated by abscisic acid (ABA) .
  • ABA abscisic acid
  • levels of the plant hormone ABA are known to fluctuate under conditions of cold or desiccation.
  • Himmelbach, A., et al. (1998) Phil. Trans. R. Soc. Lond. 353:1439-1444)
  • the activity of the Glb1 promoter can be differentially affected by environmental stress.
  • the present invention relates to an isolated nucleic acid comprising a member selected from the group consisting of: a) nucleic acids capable of driving expression in the carpel, embryo scutellum, pedicel, nucellus, pericarp, aleurone, or pedicel-forming region of a developing seed; b) nucleic acids capable of driving expression in the carpel, embryo scutellum, pedicel, nucellus, pericarp, aleurone, or pedicel-forming region of a developing seed during critical periods of seed development; c) nucleic acids capable of driving expression in the carpel, embryo scutellum, pedicel, nucellus, pericarp, aleurone, or pedicel-forming region of a developing seed during favorable or unfavorable growing conditions; d) nucleic acids comprising a functional variant or fragment of at least 20 contiguous nucleotides of the sequence set forth in SEQ ID NO 1 ; e)
  • the present invention relates to expression cassettes comprising the promoter operably linked to a nucleotide sequence, vectors containing the expression cassette, and plants stably transformed with at least one expression cassette.
  • the present invention relates to a method for modulating expression in the seed of a stably transformed plant comprising the steps of (a) transforming a plant cell with an expression cassette comprising the promoter of the present invention operably linked to at least one nucleotide sequence; (b) growing the plant cell under plant growing conditions and (c) regenerating a stably transformed plant from the plant cell wherein said linked nucleotide sequence is expressed in the seed.
  • a nucleotide sequence that allows initiation of transcription in seed.
  • the sequence of the invention comprises transcriptional initiation regions associated with seed formation and seed tissues.
  • compositions of the present invention comprise a novel nucleotide sequence for a plant promoter, more particularly a seed-preferred promoter.
  • seed or “kernel” is intended to include the grain or ripened ovule of a plant, or more broadly, a propagative plant structure.
  • seed and kernel are used interchangeably herein.
  • seed-preferred is intended favored expression in the seed, including at least one of embryo, seed or kernel, pericarp, endosperm, nucellar projection, nucellus, aleurone, pedicel, and the like.
  • heterologous nucleotide sequence is intended a sequence that is not naturally occurring with the promoter sequence. While this nucleotide sequence is heterologous to the promoter sequence, it may be homologous (native) or heterologous (foreign) to the plant host.
  • promoter is intended a regulatory region of DNA usually comprising a TATA box capable of directing RNA polymerase II to initiate RNA synthesis at the appropriate transcription initiation site for a particular coding sequence.
  • a promoter can additionally comprise other recognition sequences generally positioned upstream or 5' to the TATA box, referred to as upstream promoter elements, which influence the transcription initiation rate. It is recognized that having identified the nucleotide sequences for the promoter region disclosed herein, it is within the state of the art to isolate and identify further regulatory elements in the 5' untranslated region upstream from the particular promoter region identified herein.
  • the promoter region disclosed herein is generally further defined by comprising upstream regulatory elements such as those responsible for tissue and temporal expression of the coding sequence, enhancers and the like.
  • upstream regulatory elements such as those responsible for tissue and temporal expression of the coding sequence, enhancers and the like.
  • the promoter elements which enable expression in the desired tissue such as the seed can be identified, isolated, and used with other core promoters to confirm seed-preferred expression.
  • the isolated promoter sequence of the present invention can be modified to provide for a range of expression levels of the heterologous nucleotide sequence. Less than the entire promoter region can be utilized and the ability to drive seed- preferred expression retained. However, it is recognized that expression levels of mRNA can be decreased with deletions of portions of the promoter sequence. Thus, the promoter can be modified to be a weak or strong promoter. Generally, by “weak promoter” is intended a promoter that drives expression of a coding sequence at a low level. By “low level” is intended levels of about 1/10,000 transcripts to about 1/100,000 transcripts to about 1/500,000 transcripts.
  • a strong promoter drives expression of a coding sequence at a high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1 ,000 transcripts.
  • at least about 20 nucleotides of an isolated promoter sequence will be used to drive expression of a nucleotide sequence.
  • shorter segments of a promoter may be effective in driving expression, and may particularly enhance expression within specific tissues.
  • Enhancers can be utilized in combination with the promoter regions of the invention. Enhancers are nucleotide sequences that act to increase the expression of a promoter region. Enhancers are known in the art and include the SV40 enhancer region, the 35S enhancer element, and the like.
  • isolated refers to material, such as a nucleic acid or a protein, which is: (1 ) substantially or essentially free from components which normally accompany or interact with it as found in its natural environment.
  • the isolated material optionally comprises material not found with the material in its natural environment; or (2) if the material is in its natural environment, the material has been synthetically altered or synthetically produced by deliberate human intervention and/or placed at a different location within the cell.
  • the synthetic alteration or creation of the material can be performed on the material within or apart from its natural state. For example, a naturally-occurring nucleic acid becomes an isolated nucleic acid if it is altered or produced by non-natural, synthetic methods, or if it is transcribed from DNA which has been altered or produced by non-natural, synthetic methods.
  • the isolated nucleic acid may also be produced by the synthetic re-arrangement ("shuffling") of a part or parts of one or more allelic forms of the gene of interest. Likewise, a naturally-occurring nucleic acid (e.g., a promoter) becomes isolated if it is introduced to a different locus of the genome. Nucleic acids which are "isolated,” as defined herein, are also referred to as “heterologous" nucleic acids.
  • sequence for the promoter region of the present invention is set forth in SEQ ID NO 1.
  • the promoter region of the invention may be isolated from any plant, including, but not limited to, barley (Hordeum vulgare), maize (Zea mays), canola (Brassica napus, Brassica rapa ssp.), alfalfa (Medicago sativa), rice (Oryza sativa), rye (Secale cereale), sorghum (Sorghum bicolor, Sorghum vulgare), sunflower (Helianthus annuus), wheat (Triticum aestivum), soybean (Glycine max), tobacco (Nicotiana tabacum), potato (Solanum tuberosum), peanut (Arachis hypogaea), cotton (Gossypium hirsutum), sweet potato (Ipomoea batatus), cassava (Manihot esculenta), coffee (Cofea spp.), coconut (Cocos nucifera), pineapple (Ananas comosus), citrus trees (Citrus spp.),
  • Promoter sequences from other plants may be isolated according to well- known techniques based on their sequence homology to the promoter sequence set forth herein. In these techniques, all or part of the known promoter sequence is used as a probe which selectively hybridizes to other sequences present in a population of cloned genomic DNA fragments (i.e. genomic libraries) from a chosen organism. Methods are readily available in the art for the hybridization of nucleic acid sequences.
  • the entire promoter sequence or portions thereof can be used as a probe capable of specifically hybridizing to corresponding promoter sequences.
  • probes include sequences that are unique and are preferably at least about 10 nucleotides in length, and most preferably at least about 20 nucleotides in length.
  • Such probes can be used to amplify corresponding promoter sequences from a chosen organism by the well-known process of polymerase chain reaction (PCR). This technique can be used to isolate additional promoter sequences from a desired organism or as a diagnostic assay to determine the presence of the promoter sequence in an organism. Examples include hybridization screening of plated DNA libraries (either plaques or colonies; see e.g.
  • stringent conditions or “stringent hybridization conditions” includes reference to conditions under which a probe will hybridize to its target sequence, to a detectably greater degree than to other sequences (e.g., at least 2- fold over background).
  • Stringent conditions are target-sequence-dependent and will differ depending on the structure of the polynucleotide. By controlling the stringency of the hybridization and/or washing conditions, target sequences can be identified which are 100% complementary to a probe (homologous probing).
  • probes of this type are in a range of about 1000 nucleotides in length to about 250 nucleotides in length.
  • sequences that correspond to the promoter sequence of the present invention and hybridize to the promoter sequence disclosed herein will be at least 50% homologous, 70% homologous, and even 85% homologous or more with the disclosed sequence. That is, the sequence similarity between probe and target may range, sharing at least about 50%, about 70%, and even about 85% sequence similarity.
  • stringent wash temperature conditions are selected to be about 5°C to about 2°C lower than the melting point (T m ) for the specific sequence at a defined ionic strength and pH.
  • T m melting point
  • the melting point, or denaturation, of DNA occurs over a narrow temperature range and represents the disruption of the double helix into its complementary single strands. The process is described by the temperature of the midpoint of transition, T m , which is also called the melting temperature. Formulas are available in the art for the determination of melting temperatures.
  • Preferred hybridization conditions for the promoter sequence of the invention include hybridization at 42°C in 50%(w/v) formamide, 6X SSC, 0.5%(w/v) SDS, 100 ⁇ g/ml salmon sperm DNA.
  • Exemplary low stringency washing conditions include hybridization at 42°C in a solution of 2X SSC, 0.5% (w/v) SDS for 30 minutes and repeating.
  • Exemplary moderate stringency conditions include a wash in 2X SSC, 0.5% (w/v) SDS at 50°C for 30 minutes and repeating.
  • Exemplary high stringency conditions include a wash in 2X SSC, 0.5% (w/v) SDS, at 65°C for 30 minutes and repeating. Sequences that correspond to the promoter of the present invention may be obtained using all the above conditions. For purposes of defining the invention, the high stringency conditions are used.
  • Optimal alignment of sequences for comparison may be conducted by the local homology algorithm of Smith and Waterman, Adv. Appl. Math. 2: 482 (1981 ); by the homology alignment algorithm of Needleman and Wunsch, J. Mol. Biol. 48: 443 (1970); by the search for similarity method of Pearson and Lipman, Proc. Natl. Acad. Sci.
  • Sequence fragments with high percent identity to the sequence of the present invention also refer to those fragments of a particular promoter nucleotide sequence disclosed herein that operate to promote the seed-preferred expression of an operably-linked heterologous nucleotide sequence. These fragments will comprise at least about 20 contiguous nucleotides, preferably at least about 50 contiguous nucleotides, more preferably at least about 75 contiguous nucleotides, even more preferably at least about 100 contiguous nucleotides of the particular promoter nucleotide sequence disclosed herein. The nucleotides of such fragments will usually comprise the TATA recognition sequence of the particular promoter sequence.
  • Such fragments can be obtained by use of restriction enzymes to cleave the naturally occurring promoter nucleotide sequences disclosed herein; by synthesizing a nucleotide sequence from the naturally occurring promoter DNA sequence; or can be obtained through the use of PCR technology. See particularly, Mullis et al. (1987) Methods Enzymol. 155:335-350, and Erlich, ed. (1989) PCR Technology (Stockton Press, New York). Again, variants of these promoter fragments, such as those resulting from site-directed mutagenesis, are encompassed by the compositions of the present invention.
  • Nucleotide sequences comprising at least about 20 contiguous sequences of the sequence set forth in SEQ ID NO 1 are encompassed. These sequences can be isolated by hybridization, PCR, and the like. Such sequences encompass fragments capable of driving seed-preferred expression, fragments useful as probes to identify similar sequences, as well as elements responsible for temporal or tissue specificity.
  • a regulatory "variant" is a modified form of a regulatory sequence wherein one or more bases have been modified, removed or added.
  • a routine way to remove part of a DNA sequence is to use an exonuclease in combination with DNA amplification to produce unidirectional nested deletions of double stranded DNA clones.
  • a commercial kit for this purpose is sold under the trade name Exo-SizeTM (New England Biolabs, Beverly, Mass.).
  • this procedure entails incubating exonuclease III with DNA to progressively remove nucleotides in the 3' to 5' direction at 5' overhangs, blunt ends or nicks in the DNA template.
  • exonuclease III is unable to remove nucleotides at 3', 4-base overhangs. Timed digestion of a clone with this enzyme produces unidirectional nested deletions.
  • a regulatory sequence variant is a promoter formed by one or more deletions from a larger promoter.
  • the 5' portion of a promoter up to the TATA box near the transcription start site can be deleted without abolishing promoter activity, as described by Zhu et al., The Plant Cell 7: 1681-89 (1995).
  • Such variants should retain promoter activity, particularly the ability to drive expression in seed or seed tissues.
  • Biologically active variants include, for example, the native promoter sequences of the invention having one or more nucleotide substitutions, deletions or insertions.
  • Promoter activity can be measured by Northern blot analysis, reporter activity measurements when using transcriptional fusions, and the like. See, for example, Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.), herein incorporated by reference.
  • the nucleotide sequence for the promoter of the invention can be provided in expression cassettes along with heterologous nucleotide sequences for expression in the plant of interest, more particularly in the seed of the plant.
  • Such an expression cassette is provided with a plurality of restriction sites for insertion of the nucleotide sequence to be under the transcriptional regulation of the promoter.
  • genes of interest expressed by the promoter of the invention can be used for varying the phenotype of seeds. This can be achieved by increasing expression of endogenous or exogenous products in seeds. Alternatively, the results can be achieved by providing for a reduction of expression of one or more endogenous products, particularly enzymes or cofactors in the seed. These modifications may result in a change in phenotype of the transformed seed.
  • genes of interest for the purposes of the present invention include, for example, those genes involved in information, such as Zinc fingers, those involved in communication, such as kinases, and those involved in housekeeping, such as heat shock proteins. More specific categories of transgenes include genes encoding important traits for agronomic quality, insect resistance, disease resistance, herbicide resistance, and grain characteristics. Still other categories of transgenes include genes for inducing expression of exogenous products such as enzymes, cofactors, and hormones from plants and other eukaryotes as well as prokaryotic organisms. It is recognized that any gene of interest, including the native coding sequence, can be operably linked to the promoter of the invention and expressed in the seed.
  • Modifications that affect grain traits include altering the levels of saturated and unsaturated fatty acids. Likewise, increasing the levels of lysine- and sulfur- containing amino acids may be desired, as well as modifications of the amount and/or type of starch contained in the seed. Examples of hordothionin protein modifications are described in PCT/US94/382 filed April 10, 1997; PCT/US96/08219 filed March 26, 1997; PCT/US96/08220 filed March 26, 1997 and U.S. Pat. No. 5,703,409 issued December 30, 1997; the disclosures of which are incorporated herein by reference.
  • the promoter of the instant invention modulates genes encoding proteins which act as cell cycle regulators, or which control carbohydrate metabolism or phytohormone levels, as has been shown in tobacco and canola with other tissue-preferred promoters.
  • proteins which act as cell cycle regulators, or which control carbohydrate metabolism or phytohormone levels, as has been shown in tobacco and canola with other tissue-preferred promoters.
  • Expression of endogenous or heterologous nucleotides under the direction of the promoter may result in maintenance of a desirable seed phenotype under adverse environmental conditions.
  • the gene encoding the barley high lysine polypeptide is derived from barley chymotrypsin inhibitor, PCT/US97/20441 filed November 1 , 1996 and PCT/US97/20441 filed October 31 , 1997; the disclosures of each are incorporated herein by reference.
  • Other proteins include methionine- rich plant proteins such as from sunflower seed, Lilley et al. (1989) Proceedings of the World Congress on Vegetable Protein Utilization in Human Foods and Animal Feedstuffs, Applewhite, H.
  • Agronomic traits in seeds can be improved by altering expression of genes that affect the response of seed growth and development during environmental stress, Cheikh-N et al., (1994) Plant Physiol. 106(1 ):45-51 , and genes controlling carbohydrate metabolism to reduce seed abortion in maize, Zinselmeier et al. (1995) Plant Physiol. 107(2):385-391.
  • Insect resistance genes may encode resistance to pests that have great yield drag such as rootworm, cutworm, European Corn Borer, and the like.
  • Such genes include, for example, Bacillus thuringiensis endotoxin genes, U.S. Pat. Nos. 5,366,892; 5,747,450; 5,737,514; 5,723,756; 5,593,881 ; Geiser ef al. (1986) Gene 48:109; lectins, Van Damme ef al. (1994) Plant Mot. Biol. 24:825; and the like.
  • Genes encoding disease resistance traits include detoxification genes, such as against fumonosin (PCT/US95/10284 filed June 7, 1995); avirulence (avr) and disease resistance (R) genes Jones ef al. (1994) Science 266:789; Martin et al. (1993) Science 262:1432; Mindrinos ef al. (1994) Cell 78:1089; and the like.
  • Alterations in gene expression may also affect the type or amount of products of commercial interest; for example, starch for the production of paper, textiles and ethanol.
  • Another important commercial use of transformed plants is the production of polymers and bioplastics such as described in U.S. Patent No. 5,602,321 issued February 11 , 1997.
  • Genes such as B-Ketothiolase, PHBase (polyhydroxybutyrate synthase) and acetoacetyl-CoA reductase (see Schubert et al. (1988) J. Bacteriol 170(12):5837-5847) facilitate expression of polyhyroxyalkanoates (PHAs).
  • the nucleotide sequence operably linked to the promoter disclosed herein can be an antisense sequence for a targeted gene.
  • antisense DNA nucleotide sequence is intended a sequence that is in inverse orientation to the 5'-to-3' normal orientation of that nucleotide sequence.
  • expression of the antisense DNA sequence prevents normal expression of the DNA nucleotide sequence for the targeted gene.
  • the antisense nucleotide sequence encodes an RNA transcript that is complementary to and capable of hybridizing with the endogenous messenger RNA (mRNA) produced by transcription of the DNA nucleotide sequence for the targeted gene. In this case, production of the native protein encoded by the targeted gene is inhibited to achieve a desired phenotypic response.
  • mRNA messenger RNA
  • the promoter sequence disclosed herein can be operably linked to antisense DNA sequences to reduce or inhibit expression of a native protein in the plant seed.
  • the expression cassette will also include at the 3' terminus of the heterologous nucleotide sequence of interest, a transcriptional and translational termination region functional in plants.
  • the termination region can be native with the promoter nucleotide sequence of the present invention, can be native with the DNA sequence of interest, or can be derived from another source.
  • Convenient termination regions are available from the Ti-plasmid of A. tumefaciens, such as the octopine synthase and nopaline synthase termination regions. See also, Guerineau et al. (1991 ) Mol. Gen. Genet. 262:141-144; Proudfoot (1991 ) Cell 64:671-674; Sanfacon et al. (1991 ) Genes Dev.
  • the expression cassettes can additionally contain 5' leader sequences.
  • leader sequences can act to enhance translation.
  • Translation leaders are known in the art and include: picornavirus leaders, for example, EMCV leader (Encephalomyocarditis 5' noncoding region), Elroy-Stein et al. (1989J Proc. Nat. Acad. Sci. USA 86:6126-6130; potyvirus leaders, for example, TEV leader (Tobacco Etch Virus), Allison et al. (1986); MDMV leader (Maize Dwarf Mosaic Virus), Virology 154:9-20; human immunoglobulin heavy-chain binding protein (BiP), Macejak et al.
  • EMCV leader Engelphalomyocarditis 5' noncoding region
  • potyvirus leaders for example, TEV leader (Tobacco Etch Virus), Allison et al.
  • the cassette can also contain sequences that enhance translation and/or mRNA stability such as introns.
  • the expression cassette can further comprise a coding sequence for a transit peptide.
  • transit peptides are well known in the art and include, but are not limited to, the transit peptide for the acyl carrier protein, the small subunit of RUBISCO, plant EPSP synthase, and the like.
  • the various DNA fragments can be manipulated, so as to provide for the DNA sequences in the proper orientation and, as appropriate, in the proper reading frame.
  • adapters or linkers can be employed to join the DNA fragments or other manipulations can be involved to provide for convenient restriction sites, removal of superfluous DNA, removal of restriction sites, or the like.
  • in vitro mutagenesis, primer repair, restriction digests, annealing, and resubstitutions, such as transitions and transversions can be involved.
  • the present invention provides vectors capable of expressing genes of interest under the control of the promoter. In general, the vectors should be functional in plant cells. At times, it may be preferable to have vectors that are functional in E.
  • E. coli e.g., production of protein for raising antibodies, DNA sequence analysis, construction of inserts, obtaining quantities of nucleic acids.
  • Vectors and procedures for cloning and expression in E. coli are discussed in Sambrook et al. (supra).
  • the transformation vector comprising the promoter sequence of the present invention operably linked to a heterologous nucleotide sequence in an expression cassette can also contain at least one additional nucleotide sequence for a gene to be cotransformed into the organism.
  • the additional sequence(s) can be provided on another transformation vector.
  • Vectors that are functional in plants can be binary plasmids derived from Agrobacterium. Such vectors are capable of transforming plant cells. These vectors contain left and right border sequences that are required for integration into the host (plant) chromosome. At minimum, between these border sequences is the gene to be expressed under control of the promoter. In preferred embodiments, a selectable marker and a reporter gene are also included. For ease of obtaining sufficient quantities of vector, a bacterial origin that allows replication in E. coli is preferred.
  • Reporter genes can be included in the transformation vectors. Examples of suitable reporter genes known in the art can be found in, for example, Jefferson et al. (1991 ) in Plant Molecular Biology Manual, ed. Gelvin et al. (Kluwer Academic Publishers), pp. 1-33; DeWet et al. (1987) Mol. Cell. Biol. 7:725-737; Goff et al. (1990) EMBO J. 9:2517-2522; Kain et al. (1995) BioTechniques 19:650-655; and Chiu et al. (1996) Current Biology 6:325-330.
  • Selectable marker genes for selection of transformed cells or tissues can be included in the transformation vectors. These can include genes that confer antibiotic resistance or resistance to herbicides. Examples of suitable selectable marker genes include, but are not limited to, genes encoding resistance to chloramphenicol, Herrera Estrella et al. (1983) EMBO J. 2:987-992; methotrexate, Herrera Estrella et al. (1983) Nature 303:209-213; Meijer et al. (1991) Plant Mol. Biol. 16:807-820; hygromycin, Waldron et al. (1985) Plant Mol. Biol. 5:103-108; Zhijian et al.
  • genes that could serve utility in the recovery of transgenic events but might not be required in the final product would include, but are not limited to, examples such as GUS ( ⁇ -glucuronidase), Jefferson (1987) Plant Mol. Biol. Rep. 5:387); GFP (green florescence protein), Chalfie et al. (1994) Science 263:802; luciferase, Teeri et al. (1989) EMBO J. 8:343; and the maize genes encoding for anthocyanin production, Ludwig et al. (1990) Science 247:449.
  • GUS ⁇ -glucuronidase
  • GFP green florescence protein
  • Chalfie et al. (1994) Science 263:802 Science 263:802
  • luciferase Teeri et al. (1989) EMBO J. 8:343
  • the transformation vector comprising the particular promoter sequence of the present invention, operably linked to a heterologous nucleotide sequence of interest in an expression cassette, can be used to transform any plant.
  • genetically modified plants, plant cells, plant tissue, seed, and the like can be obtained. Transformation protocols can vary depending on the type of plant or plant cell, i.e., monocot or dicot, targeted for transformation. Suitable methods of transforming plant cells include microinjection, Crossway et al. (1986) Biotechniques 4:320-334; electroporation, Riggs et al. (1986) Proc. Natl. Acad. Sci. USA 83:5602-5606; transformation, see for example, Townsend et al. U.S.
  • Patent 5,563,055 direct gene transfer, Paszkowski et al. (1984) EMBO J. 3:27 '17 '-2722; and ballistic particle acceleration, see for example, Sanford et al. U.S. Patent 4,945,050; Tomes et al. (1995) in Plant Cell, Tissue, and Organ Culture: Fundamental Methods, ed. Gamborg and Phillips (Springer-Verlag, Berlin); and McCabe et al. (1988) Biotechnology 6:923-926. Also see Weissinger et al. (1988) Annual Rev. Genet. 22:421-477; Sanford et al. (1987) Particulate Science and Technology 5:27-37 (onion); Christou et al.
  • the cells that have been transformed can be grown into plants in accordance with conventional ways. See, for example, McCormick et al. (1986) Plant Cell Reports 5:81-84. These plants can then be grown, and pollinated with the same transformed strain or different strains. The resulting hybrid having seed- preferred expression of the desired phenotypic characteristic can then be identified. Two or more generations can be grown to ensure that seed-preferred expression of the desired phenotypic characteristic is stably maintained and inherited.
  • the primers and barley genomic DNA were used in conjunction with the
  • GenomeWalker Kit (Clontech) to isolate the promoter. The manufacturer's protocol was followed and approximately 1.3 Kb of 5' sequence were obtained. Analysis of the upstream sequence revealed no obvious control element motifs. An approximately 1-Kb fragment of the 5' upstream sequence, starting at the first methionine of the barley coding sequence, was then isolated. Two primers (SEQ ID No. 5: CCCAAGCTTTACGTTTGAGACGTATCATGTCG and SEQ ID No. 6: CGGGATCCCGCTCCTTGCTCGTGCTGGCGAAG ) with restriction sites were designed and PCR was used to isolate the fragment using techniques known to those of skill in the art. The fragment was 1091 bp long (SEQ ID NO. 1 ), and was designated Nude The DNA was inserted into a transformation vector (see Example 2, below). The construct was transformed into maize and the plants were used to evaluate promoter activity.
  • the Agrobacterium strain utilized in this example was modified to contain nucleic acid encoding the Nude promoter and a GUS reporter gene to be expressed in the transformed cells.
  • the nucleic acid to be transferred is incorporated into the T-region and is flanked by at least one T-DNA border sequence.
  • the T-region is distinct from the vir region whose functions are responsible for transfer and integration.
  • Binary vector systems have been developed where the manipulated disarmed T-DNA carrying foreign DNA and the vir functions are present on separate plasmids.
  • a modified T-DNA region comprising foreign DNA (the nucleic acid to be transferred) is constructed in a small plasmid which replicates in E. coli.
  • This plasmid is transferred conjugatively in a tri-parental mating into A. tumefaciens which contains a compatible plasmid-carrying virulence gene.
  • the vir functions are supplied in trans to transfer the T-DNA into the plant genome.
  • Preferred vectors are super-binary vectors. See, for example, U.S. Patent No. 5,591 ,616 and EPA 0604662A1 , herein incorporated by reference.
  • Such a super-binary vector has been constructed containing a DNA region originating from the virulence region of Ti plasmid pTiBo542 (Jin et al. (1987) J. Bacteriol 169:4417-4425) contained in a super-virulent Agrobacterium tumefaciens A281 exhibiting extremely high transformation efficiency (Hood et al. (1984) Biotechnol. 2:702-709; Hood et al. (1986) J. Bacteriol.
  • Patent Appl. No. 4-222527, EP-A-504,869, EP-A-604,662, and U.S. Patent No. 5,591 ,616 herein incorporated by reference
  • pTOK233 Komari, T. (1990) Plant Cell Reports 9:303-306; and Ishida et al. (1996) Nature Biotechnology 74:745; herein incorporated by reference
  • Other super-binary vectors may be constructed by the methods set forth in the above references.
  • super-binary vector pTOK162 is capable of replication in both E. coli and in A. tumefaciens.
  • the vector contains the virB, virC, and virG genes from the virulence region of pTiBo542.
  • the plasmid also contains an antibiotic resistance gene, a selectable marker gene, and the nucleic acid of interest to be transformed into the plant.
  • the T-region of the super-binary vectors and other vectors for use in gene expression are constructed to have restriction sites for the insertion of the genes to be delivered.
  • the DNA to be transformed can be inserted in the T- DNA region of the vector by utilizing in vivo homologous recombination. See, Herrera-Esterella et al. (1983) EMBO J. 2:987-995; Horch et al. (1984) Science 223:496-498).
  • homologous recombination relies on the fact that the super- binary vector has a region homologous with a region of pBR322 or other similar plasmid.
  • the vectors of this example were constructed using standard molecular biology techniques known to those of ordinary skill in the art.
  • a reporter gene and a selectable marker gene were inserted between the T-DNA borders of a superbinary vector.
  • the reporter gene was the ⁇ -glucuronidase (GUS) gene (Jefferson, R.A. et al., 1986, Proc. Natl. Acad. Sci. (USA) 83:8447-8451 ) into whose coding region was inserted the second intron from the potato ST-LS1 gene (Vancanneyt et al., Mol. Gen. Genet. 220:245-250, 1990), to produce intron-GUS, in order to prevent expression of the gene in Agrobacterium (see Ohta, S.
  • a Cauliflower Mosaic Virus 35S promoter with a duplicated enhancer region (2X35S; bases -421 to -90 and -421 to +2 from Gardner et al., Nucl. Acids Res. 9:2871-2888, 1981 ) was created.
  • a fragment containing Omega-prime leader sequence (Gallie, D.R., et al., 1987, Nucleic Acids Research 15(8):3257-3273) was inserted downstream of the 35S promoter followed by a fragment containing the first intron of the maize alcohol dehydrogenase gene ADH1-S (Dennis et al., Nucl. Acids Res. 12:3983-3990, 1984).
  • the BAR coding sequence (Thompson et al., EMBO J. 6:2519-2523, 1987) was cloned downstream of the leader sequence, with the pinll terminator ligated downstream of BAR, to create the BAR expression cassette.
  • the plasmid was constructed by inserting the GUS expression cassette and the BAR expression cassette between the right and left T-DNA borders in pSB11.
  • the GUS cassette is inserted proximal to the right T-DNA border.
  • the Nude promoter fragment was inserted into the vector in front of the intron-GUS gene.
  • the plasmid pSB11 was obtained from Japan Tobacco Inc. (Tokyo, Japan).
  • the construction of pSB11 from pSB21 and the construction of pSB21 from starting vectors is described by Komari et al. (1996, Plant J. 10:165- 174).
  • the T-DNA of this plasmid was integrated into the superbinary plasmid pSB1 (Saito et al., EP 672 752 A1 ) by homologous recombination between the two plasmids.
  • the plasmid pSB1 was also obtained from Japan Tobacco Inc.
  • E. coli strain HB101 containing the plasmid containing the Nud e promoter was mated with Agrobacterium strain LBA4404 harboring pSB1 to create the cointegrate plasmid in the Agrobacterium tumefaciens strain LBA4404 using the method of Ditta et al., (Proc. Natl. Acad. Sci.
  • the resulting co-integrated plasmid was transformed into the genotypes (1 ) Hi-ll and (2) Hi-ll x PHN46. (See U.S. Patent No. 5,567,861 for more information about PHN46.) TO plants were generated and promoter analysis was conducted on T1 seed from both genotypes.
  • Immature kernels from 21 transgenic events were collected at specific intervals after pollination, starting at 0 DAP and extending to 20 DAP. Each kernel was dissected vertically from silk scar to pedicel and was examined by histochemical staining. Specifically, each section was incubated in a solution of 0.1 M sodium phosphate buffer, pH 7.0, containing 0.5% X-gluc (5-bromo-4- chloro-3-indolyl- ⁇ -D-glucuronic acid, sodium salt, first dissolved in DMSO) and 0.1% Triton X-100. Sections were incubated overnight at 37°C.
  • Plasmids containing polynucleotide sequences of the invention were deposited on June 29, 2000, with the American Type Culture Collection (ATCC), 10801 University Boulevard, Manassas, Virginia USA, 20110-2209, and assigned Accession No. PTA-2176. This deposit will be maintained under the terms of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure. In addition, during the pendency of this patent application, access to the deposited cultures will be available to the Commissioner of Patents and Trademarks and to persons determined by the Commissioner to be entitled thereto under 37 C.F.R. ⁇ 114 and 35 U.S.C. ⁇ 122.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Developmental Biology & Embryology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PCT/US2000/030537 1999-11-02 2000-11-02 Seed-preferred promoter from barley WO2001032856A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
HU0203063A HUP0203063A3 (en) 1999-11-02 2000-11-02 Seed-preferred promoter from barley
EP00976984A EP1226261A2 (en) 1999-11-02 2000-11-02 Seed-preferred promoter from barley
MXPA02004307A MXPA02004307A (es) 1999-11-02 2000-11-02 Promotor de semilla seleccionada de cebada.
CA002389759A CA2389759A1 (en) 1999-11-02 2000-11-02 Seed-preferred promoter from barley
AU14684/01A AU1468401A (en) 1999-11-02 2000-11-02 Seed-preferred promoter from barley

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16311499P 1999-11-02 1999-11-02
US60/163,114 1999-11-02

Publications (2)

Publication Number Publication Date
WO2001032856A2 true WO2001032856A2 (en) 2001-05-10
WO2001032856A3 WO2001032856A3 (en) 2001-09-27

Family

ID=22588548

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/030537 WO2001032856A2 (en) 1999-11-02 2000-11-02 Seed-preferred promoter from barley

Country Status (6)

Country Link
EP (1) EP1226261A2 (hu)
AU (1) AU1468401A (hu)
CA (1) CA2389759A1 (hu)
HU (1) HUP0203063A3 (hu)
MX (1) MXPA02004307A (hu)
WO (1) WO2001032856A2 (hu)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008961A2 (en) * 1996-08-30 1998-03-05 Olsen Odd Arne Endosperm and nucellus specific genes, promoters and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008961A2 (en) * 1996-08-30 1998-03-05 Olsen Odd Arne Endosperm and nucellus specific genes, promoters and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [Online] EBI; Nucleotide sequence accession number AF108009, 2 August 1999 (1999-08-02) FEUILLET C. AND KELLER B.: "Hordeum vulgare HV1PST (Hv1Pst) gene, complete cds." XP002165300 *
DATABASE EMBL [Online] EBI; Nucleotide sequence accession number AP000426, 13 September 1999 (1999-09-13) SHIMIZU N. ET AL.: "Homo sapiens genomic DNA, chromosome 8q23, clone:KB1107E3" XP002165301 *
DOAN D N P ET AL: "ISOLATION OF MOLECULAR MARKERS FROM THE BARLEY ENDOSPERM COENOCYTE AND THE SURROUNDING NUCELLUS CELL LAYERS" PLANT MOLECULAR BIOLOGY,NL,NIJHOFF PUBLISHERS, DORDRECHT, vol. 31, no. 4, 1 July 1996 (1996-07-01), pages 877-886, XP002051184 ISSN: 0167-4412 cited in the application *

Also Published As

Publication number Publication date
AU1468401A (en) 2001-05-14
MXPA02004307A (es) 2002-10-31
HUP0203063A2 (hu) 2002-12-28
CA2389759A1 (en) 2001-05-10
HUP0203063A3 (en) 2004-10-28
EP1226261A2 (en) 2002-07-31
WO2001032856A3 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
US6403862B1 (en) Seed-preferred promoter from maize
CA2332628C (en) Seed-preferred promoters
US6407315B1 (en) Seed-preferred promoter from barley
US6903205B2 (en) Seed-preferred promoters from end genes
US7432418B2 (en) Seed-preferred regulatory elements and uses thereof
US7321031B2 (en) Seed preferred regulatory elements
US7211712B2 (en) Seed-preferred regulatory elements
US6921815B2 (en) Cytokinin Oxidase Promoter from Maize
US8044263B2 (en) Cytokinin oxidase promoter from maize
US20040210043A1 (en) Seed preferred regulatory elements
AU2003218155B2 (en) Early inflorescence-preferred regulatory elements and uses thereof
US20070238179A1 (en) Cell Division and Proliferation Preferred Regulatory Elements and Uses Thereof
EP1226261A2 (en) Seed-preferred promoter from barley

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/004307

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2389759

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000976984

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 14684/01

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2000976984

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000976984

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)